Shanghai, China

Hai Wu

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Hai Wu

Introduction

Hai Wu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. With a total of 10 patents to his name, he has made remarkable advancements in the development of therapeutic antibodies.

Latest Patents

Among his latest patents is the "Anti-IL-17A antibody and use thereof." This invention provides an antibody or a functional fragment that specifically binds to IL-17A with high affinity. It also includes a nucleic acid molecule encoding the antibody, an expression vector, and a host cell for expressing the antibody. Furthermore, it outlines a method for preparing the antibody and a pharmaceutical composition for treating immune dysfunction diseases. Another notable patent is the "Anti-BTLA antibody," which relates to an anti-BTLA antibody or an antigen-binding fragment comprising specific light and heavy chain CDR domains. This invention also includes a nucleic acid molecule encoding the antibody, a corresponding expression vector, and a host cell, along with therapeutic uses for the antibody.

Career Highlights

Hai Wu has worked with notable companies such as Junmeng Biosciences Co., Ltd. and Intel Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Throughout his career, Hai Wu has collaborated with talented individuals, including Hui Feng and Jian Yao. These collaborations have further enhanced his research and development efforts.

Conclusion

Hai Wu's innovative work in the field of biotechnology, particularly in the development of therapeutic antibodies, showcases his significant contributions to science and medicine. His patents reflect a commitment to addressing critical health challenges through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…